|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Activity of SUl1248, a muhitargeted inhibitor of vascular endothelial growth faclor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 2 | Activity of SUl1248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor re- ceptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 3 | Activity of SUl1248 ,a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson M D Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 4 | Activity of SU11248,a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor,in patients with metastatic renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | Journal of Clinical Oncology2006，，01： | 1 |
| 5 | Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma显示文摘 | Thompson JA Curti BD Redman BG | 2008 | J Clin Oncol2008，26，16： | 1 |
| 6 | Activity of SU 11248, a muhitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in pa- tients with metastatic renal cell cawinoma 显示文摘 | Motzer RJ Michaelson MD Redman BG | 2007 | J Clin Oncol2007，24，1： | 1 |
| 7 | Activity of SU111248, a muhitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma显示文摘 | Motzer RJ Miehaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 8 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor, in patients with metastatic renal cell carcinoma显示文摘 | Motzer R J Michaelson D Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 9 | Immunotherapy of kidney cancer 显示文摘 | Grivas PD Redman BG | 2011 | Curr Clin Pharmacol2011，6，3： | 1 |
| 10 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 11 | Oral etoposide in the treatment of hormone refractory prostate cancer显示文摘 | Pienta K Redman BG | 1994 | Cancer1994，74，1： | 1 |
| 12 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet -derived rowth factor receptor in patients with metastatic renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | J Clin Oncol2006，，： | 1 |
| 13 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patientswith metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 14 | Phase I/II study of sunitinib malate in combination with gefitinib in patients(pts) with metastatic renal cell carcinoma(mRCC) 显示文摘 | PATEL PH KONDAGUNTA GV REDMAN BG | 2007 | J Clin Oncol2007，25，18： | 1 |
| 15 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 16 | Phase I b trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma 显示文摘 | Redman BG Chang AE Whitfield J | 2008 | J Immunother2008，31，6： | 1 |
| 17 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer ILl Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 18 | Activity of SU11248, a muhitargeted inhibitor of vascular endothelial growth factor receptor and platelet - derived growth factor receptor, in patients with metastatic renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 19 | Activity of SUl1248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor re- ceptor, in patients with metastatic renal cell carcinoma显示文摘 | Motzer RJ Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 20 | Activity of SUl1248, a multitargeted inhibitor of vascular endo- thelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carci- noma显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员